Genmab (GMAB) operating margin

Operating margin · fiscal 2025
33.6%

Genmab (GMAB) had an operating margin of 33.6% in fiscal 2025 (the year ended December 31, 2025). That is 1.1 percentage points higher than the 32.5% of fiscal 2024. Figures as of 17 Nov 2026, 21:56 UTC, from Yahoo Finance.

Key facts

Operating margin, fiscal 2025
33.6%
Change on fiscal 2024
+1.1 pts
Highest on record
43.2%fiscal 2022
Lowest on record
32.3%fiscal 2023
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Genmab operating margin, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was 43.2% in fiscal 2022 and the lowest 32.3% in fiscal 2023. The fiscal 2025 figure is higher than in 67% of the 3 earlier fiscal years on record, whose median is 32.5%.

Gross margin was 93.6% in fiscal 2025. Net margin was 25.9% in fiscal 2025.

History · 4 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Gross margin
  • Net margin

Genmab operating margin, year by year

Genmab (GMAB) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedGross marginNet margin
202533.6% 1.1 pts up93.6%25.9%
202432.5% 0.2 pts up95.4%36.3%
202332.3% 10.9 pts down98.6%26.4%
202243.2%—100.0%37.6%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of Genmab and comparable companies
CompanyOperating marginFiscal year
Mettler-Toledo International MTD27.8%2025
Centene CNC-0.2%2025
Genmab GMAB33.6%2025
Illumina ILMN18.8%2025
ResMed RMD33.8%2026
Zoetis ZTS38.0%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on GMAB

Genmab, figure by figure

Genmab (GMAB) overview: price, valuation and scorecardAll health care companies by market value

Genmab operating margin: questions and answers

What is Genmab's operating margin?

Genmab (GMAB) had an operating margin of 33.6% in fiscal 2025 (the year ended December 31, 2025). That is 1.1 percentage points higher than the 32.5% of fiscal 2024.

Is Genmab's operating margin high or low compared with its own history?

The fiscal 2025 figure is higher than in 67% of the 3 earlier fiscal years on record, whose median is 32.5%.

What are the highest and lowest operating margin figures on record for Genmab?

Across the 4 fiscal years on record (2022–2025), the highest was 43.2% in fiscal 2022 and the lowest 32.3% in fiscal 2023.

What are Genmab's gross and net margins?

Gross margin was 93.6% in fiscal 2025. Net margin was 25.9% in fiscal 2025.

How is Genmab's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Genmab (GMAB) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/GMAB/operating-margin

Underlying data: Yahoo Finance.